Displaying 51-94 of 94 result(s).
Recent Articles
- Sherri Evers Steps Up as North America Lubes General Manager
- NextGen Digital Ventures Into $1M Private Placement Financing
- E2open's Q3 2025 Results Highlight Growth and Strategy
- Tesla Issues Recall for Over 239,000 Vehicles Due to Camera Issues
- Boston International Holdings Reports Loss and Strategy Shift
- Åsa Thunman's Departure from Sandvik and Future Plans
- European Companies Trim Workforce Amid Economic Challenges
- Major Brokerages Anticipate Steady Rates at Fed's Upcoming Meeting
- Record Growth in Concierge Medicine: Specialdocs Expands Network
- Cmbio® Expands Its Digital Biology Platform with Key Acquisition
- Supreme Court's Critical Decision on TikTok Ban Looms Ahead
- Intellia Therapeutics Implements Strategic Changes to Focus Growth
- Piper Sandler Boosts Nike's Rating and Price Target Significantly
- Constellation Energy's Game-Changing Acquisition of Calpine
- China Evergrande Ordered to Repay $1.8 Billion Deposit Pledges
- UBS Downgrades Tele2 to 'Sell' Amid Concerns Over Growth
- Toll Brothers Sees Growth Amid Los Angeles Wildfire Crisis
- Scottie Pippen's Stark Warning on Bitcoin's Future Trap
- ZenaTech's ZenaDrone Aims for FAA Certification in Agriculture
- Royalty Pharma's Strategic Growth and Future Prospects Unveiled
- Vikram Kapoor Joins Golconda Gold Ltd. Board as Director
- Unlocking Drug Discovery: Absci Partners with Owkin for Innovation
- Churchill Downs Inc. Plans Q4 2024 Financial Results Call
- Ranchero Gold Corp. Finalizes Debt Settlement Process Successfully
- Tourmaline Bio Appoints Dr. Paul M. Ridker to Advisory Board
- Prairie Operating Co. Advances with Shelduck South Pad Success
- Strategic Merger Between CNB Financial and ESSA Bancorp Set to Enhance Services
- Constellation Brands Showcases Impressive Q3 Fiscal Results
- Y-mAbs Welcomes Doug Gentilcore as DANYELZA Leader
- Understanding the Shift in Norges Bank's Shareholding in NKT
- Zai Lab and Vertex Join Forces to Bring Povetacicept to Asia
- Vertex and Zai Lab Enter Strategic Agreement for Pove Development
- Nektar Therapeutics Reaches Key Milestone in AD Trial Success
- Royalty Pharma's Strategic Maneuvers: Aiming for Growth and Efficiency
- Xeris Biopharma Projects Strong Revenue Growth for 2024
- Lazard Strengthens Team with New Global Head of Sports Advisory
- Baronsmead Venture Trust Unveils Major Share Subscription Offer
- GH Research Achieves Milestones in Groundbreaking Depression Trials
- Bio-Path's Ambitious 2025 Goals in Cancer and Diabetes Research
- Lantronix Welcomes Brent Stringham as New CFO Amid Growth
- Spero Therapeutics Transitions Leadership Amid Regulatory Scrutiny
- Arvinas Inc. Unveils Strategic Plans for 2025 Clinical Trials
- Baronsmead VCTs Unveil New £50 Million Investment Opportunity
- Opera Limited to Showcase Insights at Growth Conference
- Royalty Pharma's Bold Moves: Acquisition and Buyback Insights
- Net Lease Office Properties Reports Significant Asset Sales
- Alphyn Biologics Shows Promising Advances in Skin Health
- Spectral Capital Announces Aaron Christensen as New CRO
- Walgreens Boots Alliance Reports Strong Q1 Performance Insights
- Analysts Warn of Potential Economic Challenges Ahead